4.6 Review

11β-Hydroxysteroid dehydrogenases and the brain: From zero to hero, a decade of progress

期刊

FRONTIERS IN NEUROENDOCRINOLOGY
卷 32, 期 3, 页码 265-286

出版社

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.yfrne.2010.12.001

关键词

11 beta-Hydroxysteroid dehydrogenase; Glucocorticoids; Mineralocorticoids; HPA axis; Ageing; Anxiety; Developmental programming

资金

  1. Wellcome Trust [WT 079009, WT 083184]
  2. MRC [G0501596]
  3. BBSRC
  4. EPSRC
  5. ESRC
  6. Medical Research Council [G0501596, G0700704B] Funding Source: researchfish
  7. MRC [G0501596] Funding Source: UKRI

向作者/读者索取更多资源

Glucocorticoids have profound effects on brain development and adult CNS function. Excess or insufficient glucocorticoids cause myriad abnormalities from development to ageing. The actions of glucocorticoids within cells are determined not only by blood steroid levels and target cell receptor density, but also by intracellular metabolism by 11 beta-hydroxysteroid dehydrogenases (11 beta-Hsp). 11 beta-HSD1 regenerates active glucocorticoids from their inactive 11-keto derivatives and is widely expressed throughout the adult CNS. Elevated hippocampal and neocortical 11 beta-HSD1 is observed with ageing and causes cognitive decline; its deficiency prevents the emergence of cognitive defects with age. Conversely, 11 beta-HSD2 is a dehydrogenase, inactivating glucocorticoids. The major central effects of 11 beta-HSD2 occur in development, as expression of 11 beta-HSD2 is high in fetal brain and placenta. Deficient feto-placental 11 beta-HSD2 results in a life-long phenotype of anxiety and cardiometabolic disorders, consistent with early life glucocorticoid programming. (C) 2010 Elsevier Inc. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据